Status:
UNKNOWN
Early Warning and Optimization Strategy in Carotid Endarterectomy
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Carotid Stenosis
Carotid Artery Diseases
Eligibility:
FEMALE
40-80 years
Phase:
PHASE4
Brief Summary
Carotid endarterectomy has been proven effective in prevention of cerebral vascular events in patients with severe carotid artery stenosis (symptomatic,\>50%;asymptomatic,60%). But during the surgery,...
Detailed Description
AHA guidelines recommend carotid endarterectomy (CEA) for severe carotid stenosis. But during CEA, there is little chance that the patient suffer from severe hypoperfusion or stroke. So we use TCD to ...
Eligibility Criteria
Inclusion
- Carotid artery stenosis detectable by duplex ultrasound, and no previous procedure done on it, which might well need procedural treatment now with CEA or CAS.
- Already started any appropriate medical treatment (eg, statin, aspirin etc), and already recovered from any necessary coronary procedures (eg, CABG)
- Patient seems fit and willing for follow-up in person (at 1 month) and by annual letter (for at least 5 years)
- Some type of angiography (eg, MRA or CTA) has already been done that has shown that CEA .
Exclusion
- Small likelihood of worthwhile benefit (eg, very low risk of stroke because stenosis is very minor, or major co-morbidity or life-threatening disease, such as advanced cancer)
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01210937
Start Date
January 1 2010
End Date
December 1 2014
Last Update
December 24 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730